Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MeDMD: Metoprolol for Cardiomyopathy Prevention in DMD
NCT05066633Phase 3Recruiting
- Sponsor
- Medical University of Gdańsk
- Start
- Aug 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metoprolol in Duchenne muscular dystrophy (DMD), sponsored by Medical University of Gdańsk. Started Aug 2021; status: recruiting.
02
Drugs
metoprolol
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT05066633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05066633.